TGFBR2 and COVID-19: TGFBR2 was significantly upregulated in vascular ECs (P < 7.5E-6, Fig. S8A) in fatal COVID-19, while upregulation of the neuropilin-binding ligand TGFB1 (20) was observed in monocytes (Fig. S8B).